Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
about
Preclinical models of antipsychotic drug action.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Phencyclidine Disrupts the Auditory Steady State Response in RatsReversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine.Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.Ketamine alters oscillatory coupling in the hippocampus.Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.Cortical Alpha Activity in Schizoaffective Patients.Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons.Aberrant Current Source-Density and Lagged Phase Synchronization of Neural Oscillations as Markers for Emerging Psychosis.First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptorsDopamine, cognitive function, and gamma oscillations: role of D4 receptors.Optogenetically evoked gamma oscillations are disturbed by cocaine administration.Transcranial magnetic stimulation on the modulation of gamma oscillations in schizophrenia.A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo.Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity.Investigation of effects of short-term exposure to 50 HZ magnetic field on central, peripheral, and autonomic nervous systems in rats.Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations.Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus.Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.Brain-derived neurotrophic factor haploinsufficiency impairs high-frequency cortical oscillations in mice.Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs.Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing.Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets.Increased visual gamma power in schizoaffective bipolar disorder.The N-Methyl d-Aspartate Glutamate Receptor Antagonist Ketamine Disrupts the Functional State of the Corticothalamic Pathway.Effects of aberrant gamma frequency oscillations on prepulse inhibition.Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs.Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression
P2860
Q26827502-FF9479E5-FEEC-41C4-90A2-B077B34A178FQ26830533-010A76ED-5874-418C-9E4D-AD95EFFFEA8DQ28547137-AF39CDEC-609A-400C-BFEC-5A8497FF45E1Q30383064-CAA755C7-AE02-46B7-8C02-91AD980772EBQ30391868-BD8B4BED-8467-4E91-A78C-89F675348E68Q30542045-BCC130D0-E927-4977-9B79-844EBA403511Q30758231-A3BA175D-706F-448F-9FE7-3CC953C7C17FQ33658371-B81AD897-74FC-4563-AE7A-E8D43941ECEDQ34675038-B1DB8956-B923-473B-9882-EE4CC95E6728Q35738974-4C590F9C-6856-4354-8905-2D5005BD9C56Q36446517-39D3BF00-B8AC-4899-82E8-D54CC18C97DDQ36973467-C3883D46-5659-4C70-92CC-B632271B8014Q37346030-11B725C3-0555-41A2-B693-64C509391592Q38028607-52C1F11E-5B0B-43A9-8EC1-9510E10F78D4Q38122300-80A51512-C2C9-4365-BB9B-C42357C2D027Q39057006-50F91B94-BBD1-43D3-9820-FA6C3AA2B1F9Q39819933-42602437-EC13-4740-9687-8667272C62D3Q40939468-C82D541B-3B41-4F22-BD5A-EBA1AC304A9CQ43921912-4B05F657-3033-4A16-B5F4-15B744CFD9B7Q44179800-E3478450-4E38-4449-88B8-0336972141D7Q46349804-8B7D4CFD-063B-4EA4-9286-3BCA29245BE5Q47300330-E36666FE-44A2-4EFD-BC96-F69ED448ED04Q47618895-F8137B11-7D87-4F27-B260-74910313E5FBQ48113775-BF515FFF-B51C-418C-8C15-18CC21478515Q48135391-26447BC3-AEE5-4AC8-B65C-0BBD7462C67BQ48146326-60E6ABDD-A594-45FB-A01F-C74F2D4D04ADQ48609060-0AB6C40C-6EC7-403A-84B1-7DD63E58843AQ48694917-3ECDE5F9-21CF-4D64-8DE7-17310647C75DQ50643480-58764063-70F1-4671-A5D3-56D7B04D2B33Q50902921-2595778E-FA41-49B0-91D6-805AF4CEB330Q58737944-C9440A10-44FF-43AE-B6BA-4411012DE280
P2860
Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Acute administration of typica ...... amine-induced rise in γ power.
@ast
Acute administration of typica ...... amine-induced rise in γ power.
@en
type
label
Acute administration of typica ...... amine-induced rise in γ power.
@ast
Acute administration of typica ...... amine-induced rise in γ power.
@en
prefLabel
Acute administration of typica ...... amine-induced rise in γ power.
@ast
Acute administration of typica ...... amine-induced rise in γ power.
@en
P2860
P50
P1476
Acute administration of typica ...... amine-induced rise in γ power.
@en
P2093
Maya Reddy
Michael R Salzberg
P2860
P304
P356
10.1017/S1461145711000848
P577
2011-06-09T00:00:00Z